To treat or not to treat? Implementation of DOTS in Central Asia

Lancet

Volumn 361, Issue 9359, 2003, Pages 714-715

  Cox, Helen ^a   Hargreaves, Sally ^a  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

EPIDEMIC; GOVERNMENT; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INFECTION RATE; INFECTION RISK; MULTIDRUG RESISTANCE; NOTE; PRIORITY JOURNAL; SOCIOECONOMICS; TREATMENT FAILURE; TUBERCULOSIS; UZBEKISTAN; WORLD HEALTH ORGANIZATION;

EID: 0037334250     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12667-0     Document Type: Note

References (9)

1. Small I., van der Meer J., Upshur R.E.G. Acting on an environmental disaster: the case of the Aral Sea. Environ Health Persp. 109:2001;547-549.
2. WHO. Global tuberculosis control: surveillance, planning, financing. WHO/CDS/TB/2002.295. Geneva: World Health Organization, 2002. http://www.who.int/gtb/publications/globrep02/index.html (accessed Nov 28, 2002).
3. Raviglione MC. Global DOTS expansion: will we reach the targets? Presentation to 33rd IUATLD World Conference on Lung Health, Montreal, Canada, Oct 6-10, 2002. http://www.who.int/gtb/whats-new/montreal_oct02/iuatld/raviglione.ppt (accessed Jan 8, 2003).
4. Ilkhamov F.A., Jakubowski E. European observatory on health care systems: health care systems in transition. McKee M., Healy J., Falkingham J. The European Observatory on Health Care Systems: health care in Central Asia. 2001;179-193 Open University, Buckhingham.
5. Espinall M.A., Laserson K., Camacho M., et al. Determinants of drug resistant tuberculosis: analysis of 11 countries. Int J Tuberc Lung Dis. 5:2001;887-893.
6. WHO. Tuberculosis handbook. WHO/TB/98.253. Geneva: World Health Organization, 1998. http://www.who.int/gtb/publications/tbhandbook/index.htm (accessed Nov 28, 2002).
7. Conninx R., Mathieu C., Debacher M., et al. First-line tuberculosis therapy and drug-resistant Mycobacterium tuberculosis in prisons. Lancet. 353:1999;969-973.
8. Trébucq A., Anagonou S., Gninafon M., Lambregts K., Boulahbal F. Prevalence of primary and acquired resistance of mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short course chemotherapy. Int J Tuberc Lung Dis. 3:1999;466-470.
9. WHO report on the tuberculosis epidemic, 1996. Geneva: World Health Organization, 1996.